Press release -
Cardiaccs appoints Shane West as CEO
Cardiaccs, a Norwegian company developing innovative technology for direct monitoring of cardiac function, is pleased to announce the appointment of Mr. Shane West as Chief Executive Officer effective May 1st. Shane succeeds Prof. Erik Fosse who has been CEO since founding the company in 2009. Erik will continue to play a very active role in the company as Chairman of the Board of Directors.
Cardiaccs was founded in 2009 as a result of 8 years of research and development by the Intervention Centre at Oslo University Hospital in cooperation with Buskerud and Vestfold University College. In 2014, the company was granted funding by the Research Council of Norway through the FORNY2020 program to commercialize the Cardisense sensor technology. The appointment of Mr. Shane West will strengthen Cardiaccs ability to achieve regulatory approval and commercialize CardiSense with an increased focus on market and customer strategy.
Shane brings more than 15 years of global MedTech experience to Cardiaccs. He led the Customer and Market Insight function for the global GE Healthcare portfolio, where he helped drive customer-centric approaches to product and service development. Since leaving GE Healthcare at the end of 2016, Shane has focused his attention on supporting Norwegian startups and global MedTech leaders with customer and market insights through his VP of Client Relations EMEA position at Cetas Healthcare. Shane will continue in his role at Cetas Healthcare while taking on the role of CEO at Cardiaccs.
“Having come to know the CardiSense technology over the past 6 months I’m excited to be chosen to lead the company into its next exciting phase of commercialization,” said Shane West. “After listening to many physicians across the US and EU I’m convinced that CardiSense will be a valuable and sought-after monitoring tool for cardiac specialists”.
Shane has a BSc(Hons) in Cognitive Science and MBA from La Trobe University, Melbourne.
For more information please contact Cardiaccs via email@example.com or:
Aleap, a non-profit incubator, offers a community for health startups. Our mission is to facilitate innovation and value creation by developing an ecosystem for ambitious health entrepreneurs and companies to create new products better and faster. We do this by offering a broad range of critical know-how, expertise, infrastructure and international business networks.
We believe that entrepreneurship and successful startups will benefit from collaboration in a multidisciplinary environment with proactive sharing.